Test Price
2,800 AED✅ Home Collection Available
KRT9 Gene Epidermolytic Palmoplantar Keratoderma Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed Consultant Medical Genetics.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The KRT9 gene test utilizes Next-Generation Sequencing (NGS) to detect pathogenic variants in the KRT9 gene responsible for epidermolytic palmoplantar keratoderma (EPPK), a rare inherited skin disorder. This comprehensive analysis provides definitive molecular diagnosis, enabling personalized dermatologic management and informed genetic counselling.
| Feature | Our NGS Test | Conventional Sanger Sequencing |
|---|---|---|
| Gene Coverage | Full coding region + splice sites (KRT9) | Targeted hotspot mutations only |
| Sensitivity | >99.9% for single nucleotide variants & small indels | ~95% (misses deep intronic variants) |
| Turnaround Time | 3 – 4 Weeks | 6 – 8 Weeks (fragmented analysis) |
| Clinical Utility | Comprehensive diagnosis, variant of uncertain significance reclassification possible | Limited to known mutations; may miss novel variants |
Physician Insight & Safety Protocols
"Every KRT9 test we report is grounded in meticulous NGS validation and correlated with the patient's clinical phenotype. Results must always be interpreted alongside your dermatologist's assessment to rule out other keratodermas and to plan the best symptomatic relief."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Guidance
Important: This genetic test provides diagnostic information and should not be used as a substitute for ongoing clinical management. Do not alter any prescribed treatments without consulting your dermatologist. The test results may require correlation with family history and additional clinical evaluations.
Exclusion Criteria & Emergency Red Flags
- Inability to provide blood sample due to severe anaemia or untreated coagulopathy.
- Ongoing anticoagulant therapy without prior clearance from your physician.
- Acute febrile illness or active systemic infection at time of collection.
- Lack of informed consent or legal authorisation (mandatory for minors under Federal Decree-Law No. 4 of 2016 on Medical Liability).
Red Flags – Seek Immediate Medical Attention:
- Uncontrolled bleeding, fainting, or dizziness after phlebotomy.
- Signs of infection at the venipuncture site (redness, swelling, pus).
- Any severe allergic reaction following sample collection.
In case of emergency, call UAE emergency number 998 or go to the nearest hospital.
Patient FAQ & Clinical Guidance
1. What is the KRT9 gene test and why is it important?
The KRT9 NGS test identifies mutations in the KRT9 gene causing epidermolytic palmoplantar keratoderma, guiding treatment and family planning.
This test is critical for confirming the clinical diagnosis, distinguishing EPPK from other palmoplantar keratodermas, and identifying at-risk relatives through predictive testing. Early genetic diagnosis helps avoid unnecessary skin biopsies and directs targeted symptomatic care.
2. How is the sample collected and what is the turnaround time?
A simple blood draw or FTA card spot is done at home by a certified phlebotomist; results are reported within 3 to 4 weeks.
We offer convenient home collection from 8 AM to 11 PM, 7 days a week, with ISO-certified cold-chain transport. You only need a small volume of whole blood or a single drop on an FTA card – no fasting required.
3. Is this genetic test covered by insurance in the UAE?
Direct billing verification via WhatsApp (+971 54 548 8731) ensures coverage confirmation before sample collection, minimizing out-of-pocket surprises.
Many UAE insurers now include advanced genetic testing under dermatology or hereditary disease benefits. Our dedicated team will verify your policy and guide you through the approval process in compliance with UAE PDPL data privacy regulations.
UAE Regulatory & Data Privacy Adherence
Privacy and Compliance
This test is performed under DHA Facility License Number 1143. All data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genetic counselling adheres to MOHAP guidelines. ISO 9001:2015 Certified (INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | KRT9 Gene Epidermolytic Palmoplantar Keratoderma Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole Blood (3 mL) or FTA Card Dried Blood Spot |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | Q82.8 (Other specified congenital malformations of skin) |
| LOINC Code | 83025-8 (Molecular genetics analysis) |
| DHA Facility License & Address | DHA License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians